Tandem | Latest News & Updates - Mar 14, 2025 Release

Tandem received FDA clearance for its Control-IQ+ algorithm for Type 2 diabetes, expanding its market by integrating with its insulin pumps to automate insulin delivery...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Tandem

🌎 withtandem.com

Tandem is a technology company based in New York, NY, focused on accelerating access to medicine through the application of AI. It aims to build the world's largest network of doctors, patients, and first-party data to bring new therapies to market efficiently. Tandem also offers a prescription concierge service that checks prescriptions against insurance prices and various payment options, ensuring patients receive their medications quickly and affordably.


Tandem - Latest News and Updates

  • Tandem received FDA clearance for its Control-IQ+ algorithm for Type 2 diabetes, expanding its market by integrating with its insulin pumps to automate insulin delivery.
  • Tandem is currently hiring a Senior Recruiter (Contract) in the United States.
  • Tandem is hosting a puzzle night in New York on March 17 with dinner, prizes, and games, co-hosted by Bain Capital Ventures.
  • Daniela Velez, an engineer at Tandem, announced her recent role in building products to improve medication access and support drug market entry.
  • Prerna Mewawalla presented insights on BCMA-directed therapies in RRMM at the Tandem Annual Meeting on March 3, 2025.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.